BPIA filed comments with the NOSB ahead of its Fall 2026 meeting, highlighting several priorities important to biological product manufacturers and organic growers.

BPIA submitted comments to EPA in response to its Request for Information on the Innovation Challenge: Alternatives to Conventional Pesticides for Crop Desiccation.

BPIA applauds the U.S. Senate Committee on Agriculture, Nutrition, and Forestry for advancing the bipartisan Farm Bill, marking an important step toward delivering a comprehensive Farm Bill for America’s farmers, ranchers, and rural communities.

Join industry leaders, regulatory experts, formulation scientists, and inert ingredient manufacturers for the Second Annual BPIA Inerts Symposium on Wednesday, November 18, 2026, at the North Carolina Biotechnology Center in Durham, NC.

Ahead of the Senate Agriculture Committee’s markup of the Agricultural Act of 2026, BPIA voiced strong support for provisions that advance agricultural innovation, strengthen regulatory coordination, and expand grower access to biological products.

BPIA filed joint comments to Health Canada with FSAC regarding proposed regulations amending Canada’s Pest Control Products Regulations.

BPIA applauds Senate Agriculture Committee Chairman John Boozman (R-AR) for releasing the Senate Farm Bill legislative text including critical Plant Biostimulant Act language.

BPIA joined more than 100 agricultural organizations in a letter to Senate appropriators supporting adequate staffing levels at USDA’s Natural Resources Conservation Service and Farm Service Agency.

BPIA through its participation in the Food and Agriculture Climate Alliance (FACA), joined a coalition letter to Senate Agriculture Committee leadership outlining key priorities for Farm Bill reauthorization.

BPIA applauds the recent legislative momentum around fertilizer affordability and agricultural innovation, including the Plant Biostimulant Act and other related fertilizer bills.

BPIA applauds the House passage of the Farm, Food, and National Security Act of 2026, which includes several key provisions that would advance grower access to biological products, including plant biostimulants and biofertilizers.

BPIA sent a letter to House Agriculture Committee Chairman Glenn “GT” Thompson and Ranking Member Angie Craig urging passage of the Farm, Food, and National Security Act of 2026.

The BPIA 2026 Annual Meeting held in Washington, DC on March 4-6 included three tracks covering a variety of regulatory, technical, and commercial topics with speakers from EPA, USDA, CFIA, PMRA, and AAPFCO.

As we reflect on 2025, BPIA would like to thank all our partners for their continued engagement and help in promoting the biological products industry.

As the year draws to a close, we want to extend our heartfelt thanks to our members and colleagues for your engagement, leadership, and commitment to the biological products industry.

BPIA applauds last week’s announcement from the USDA in collaboration with HHS launching a $700 million Regenerative Pilot Program.

Please join us at the historic Capital Hilton in Washington, D.C., on March 4-6, 2026, for the BPIA 2026 Annual Meeting. Don’t miss the most important annual gathering for the biological products industry in North America. 

BPIA congratulates Dudley Hoskins on his confirmation as Under Secretary for the U.S. Department of Agriculture’s Marketing and Regulatory Programs.

BPIA joined a coalition of industry associations in sending a letter to Congressional leadership urging swift, bipartisan passage of the Fiscal Year 2026 Interior, Environment, and Related Agencies appropriations bill.

BPIA has submitted comments to the National Organic Standards Board in advance of its Fall 2025 Meeting.